| Breast Cancer |
1 |
1 |
| Ovary |
0 |
0.85 |
| Estrogen Receptor-Positive (ER+) Breast Cancer |
0 |
0.85 |
| Selective Estrogen Receptor Modulators |
0 |
0.52 |
| Metabolic Syndrome |
0 |
0.5 |
| BRCA |
0 |
0.85 |
| Metabolism |
0 |
0.36 |
| Genomic Medicine |
0 |
0.85 |
| Advanced and Metastatic Breast Cancer |
0 |
0.22 |
| Disease Recurrence |
0 |
0.65 |
| Genetics |
0 |
0.85 |
| Poly ADP-Ribose Polymerase (PARP) Inhibitor |
0 |
0.75 |
| Chemotherapy |
0 |
0.14 |
| Breast |
0 |
0.07 |
| Cancer |
0 |
0.07 |
| Neoadjuvant Therapy |
0 |
0.07 |